Clinical Research in Southampton
Southampton Children's Hospital

A A A Text only | Accessibility | Privacy and cookies

Home
About the Trust
Our services
Patients and visitors
Our hospitals
Education
Research
Working here
Contact us

Browse site A to Z

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z

Search results

Go To Advanced Search

Search

You could also try: middle (95), midway (2), in-between (5), transitional (47), halfway (122), intermediary (6)

Papers Trust Board - 29 November 2022

Description: Date Time Location Chair Agenda Trust Board – Open Session 29/11/2022 9:00 - 13:20 Conference Room, Heartbeat/Microsoft Teams Jenni Dou
Url: /Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2022-Trust-documents/Papers-Trust-Board-29-November-2022.pdf

Data breach - questions and answers

Description: • How did this happen? The Freedom of Information Act 2000 provides the public access to information held by public authorities. The Trust (a public body
Url: /Media/UHS-website-2019/Docs/News/Data-breach-questions-and-answers.pdf

Ménière's disease - patient information

Description: This factsheet explains what Ménière's disease is, the symptoms to look out for and how it is treated.
Url: /Media/UHS-website-2019/Patientinformation/Audiology/Ménières-disease-2563-PIL.pdf

Ipilimumab(1mg/kg)-Nivolumab(3mg/kg)

Description: Chemotherapy Protocol RENAL CANCER IPILIMUMAB (1mg/kg)-NIVOLUMAB(3mg/kg) Regimen • Renal – Ipilimumab (1mg/kg)-Nivolumab (3mg/kg) Indication • Ipilimum
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Renal-cell/Ipilimumab1mgkg-Nivolumab3mgkg.pdf

Southampton PTC - Approved chemotherapy regimens 9 June 2020

Description: Appendix B: SOUTHAMPTON PAEDIATRIC ONCOLOGY PRINCIPAL TREATMENT CENTRE List of Approved Chemotherapy Regimens Updated 9th June 2020 Review Date: June 2021 Ag
Url: /Media/UHS-website-2019/Docs/PaediatricOncology/Southampton-PTC-Approved-chemotherapy-regimens-9-June-2020.pdf

BEP5day

Description: Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 5 Day) Regimen • Germ Cell – Bleomycin-Cisplatin-Etoposide (5 day BEP) I
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/BEP5day.pdf

CHOP(21)-Cyclophosphamide-Doxorubicin-Prednisolone-Vincristine (21) Ver 1.2

Description: Chemotherapy Protocol LYMPHOMA CYCLOPHOSPHAMIDE-DOXORUBICIN-PREDNISOLONE-VINCRISTINE (21) (CHOP 21) Regimen Lymphoma – CHOP(21)-
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/CHOP21-Cyclophosphamide-Doxorubicin-Prednisolone-Vincristine-21-Ver-1.2.pdf

InP-Bleomycin-Cisplatin-Etoposide (5 day BEP) Ver1.2

Description: Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 5 Day) In-Patient Regimen Regimen Germ Cell – InP-Bleomycin-Cisplati
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/InP-Bleomycin-Cisplatin-Etoposide-5-day-BEP-Ver1.2.pdf

Bleomycin-Cisplatin-Etoposide (3 day BEP) Ver1.2

Description: Chemotherapy Protocol GERM CELL BLEOMYCIN-CISPLATIN-ETOPOSIDE (BEP 3 Day) Regimen Germ Cell – Bleomycin-Cisplatin-Etoposide (3 day BE
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Germcell/Bleomycin-Cisplatin-Etoposide-3-day-BEP-Ver1.2.pdf

Epcoritamab -Cycle 2 (Onwards)

Description: Chemotherapy Protocol LYMPHOMA EPCORITAMAB – Cycle 2 Onwards - (28 day) Regimen • Lymphoma-Epcoritamab – Cycle 2 Onw
Url: /Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Epcoritamab-Cycle-2-Onwards-Ver1.pdf

1 to 10 of 39

Previous 1 2 3 4 Next